NCT07030257: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 150 planned
- Started
- 27 Aug 2025
- Primary completion
- 15 Aug 2028
- Arms
- Dose Level 1, Dose Level 2, Dose Level 3, Dose Level 4, Dose Level 5, Dose Level 6, Expansion Arm 1, Expansion Arm 2, Expansion Arm 3, Expansion Arm 4
- Results
- None posted
- 22 Jun 2025: Trial registered
- 27 Aug 2025: Trial started